Abstract
Background Despite being a preventable complication of surgical procedures, surgical site infections (SSIs) continue to threaten public health with significant impacts on the patients and the health-care human and financial resources. With millions affected globally, there issignificant variation in the primary studies on the prevalence of SSIs in Ethiopia. Therefore, this study aimed to estimate the pooled prevalence of SSI and its associated factors among postoperative patients in Ethiopia.
Methods PubMed, Scopus, Psyinfo, African Journals Online, and Google Scholar were searched for studies that looked at SSI in postoperative patients. A funnel plot and Egger’s regression test were used to determine publication bias. The I2 statistic was used to check heterogeneity between the studies. DerSimonian and Laird random-effects model was applied to estimate the pooled effect size, odds ratios (ORs), and 95% confidence interval (CIs) across studies. The subgroup analysis was conducted by region, sample size, and year of publication. Sensitivity analysis was deployed to determine the effect of a single study on the overall estimation. Analysis was done using STATA™ Version 14 software.
Result A total of 24 studies with 13,136 study participants were included in this study. The estimated pooled prevalence of SSI in Ethiopia was 12.3% (95% CI: 10.19, 14.42). Duration of surgery > 1 hour (AOR = 1.78; 95% CI: 1.08 –2.94), diabetes mellitus (AOR = 3.25; 95% CI: 1.51–6.99), American Society of Anaesthesiologists score >1 (AOR = 2.51; 95% CI: 1.07–5.91), previous surgery (AOR = 2.5; 95% CI: 1.77–3.53), clean-contaminated wound (AOR = 2.15; 95% CI: 1.52–3.04), and preoperative hospital stay > 7 day (AOR = 5.76; 95% CI: 1.15–28.86), were significantly associated with SSI.
Conclusion The prevalence of SSI among postoperative patients in Ethiopia remains high with a pooled prevalence of 12.3% in 24 extracted studies. Therefore, situation based interventions and region context-specific preventive strategies should be developed to reduce the prevalence of SSI among postoperative patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
not applicable
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
which is declared in the main document
Abbreviations
- ASA
- American Society of Anaesthesiologists
- CI
- Confidence Interval
- AOR
- Adjusted Odds Ratio
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- SNNPR
- Southern Nations Nationalities and Peoples Region
- SSI
- Surgical Site Infection.
